Back

A breakthrough in lipid therapy: from statins to PCSK9 inhibitors.

8 April 2017 (09:55 - 09:25)
Organised by:
Congress Presentation Part of: The year in preventive cardiology Miscellaneous EAPC Premium Access EuroPrevent 2017

About the speaker

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Introduction: The ESC Journal Family on the move.
Professor U. Landmesser (Berlin, DE)
Video
Presentation thumbnail
Nutrition and non-pharmacological measures.
Professor M. Verschuren (Bilthoven, NL)
Slides Video
Presentation thumbnail
Diabetes: another breakthrough in prevention.
Professor C. Saely (Feldkirch, AT)
Slides Video
Presentation thumbnail
Closing remarks.
Professor M. Piepoli (San Donato Milanese, IT)
Slides Video

Access the full session

Session thumbnail
The year in preventive cardiology

The Event

Event poster

EuroPrevent 2017

8 April 2017 09:55 CET
You may be interested in
thumbnail
Congress Presentation
Targeting the PCSK9 pathway: where do novel therapies fit in?
26 August 2022
thumbnail
Webinar
Lipid management pathways and ESC Guidelines
10 January 2023
thumbnail
Congress Presentation
PCSK9 inhibitors: effectiveness of treatment and changes in background lipid-lowering therapy in a real world Italian population. The AT-TARGET-IT study
26 August 2022
thumbnail
Congress Presentation
Efficacy of PCSK9 inhibitors combined with statins versus statin monotherapy for secondary cardiovascular prevention: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources